The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. The Food and Drug Administration ...
In the first clinical trial of dose-adjusted EPOCH along with inotuzumab ozogamicin (InO) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), Fred Hutch Cancer Center ...
A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...
Patients with suspected acute lymphoblastic leukemia (ALL) should undergo medical history and physical examination, along with laboratory tests and imaging. Laboratory tests include a complete blood ...
Acute lymphoblastic leukemia (ALL) is known as a pediatric leukemia, with approximately half of cases occurring in children. ALL is the most common childhood malignancy, representing 75% to 80% of ...
The treatment of acute lymphoblastic leukemia in adults is extremely complex, lengthy and very stressful for patients. Compared to other types of cancer in adults, ALL is relatively rare, as a result ...
A new immunotherapy is effective in treating leukemia in adults More than three-quarters of patients with B-cell acute lymphoblastic leukemia responded to Aucatzyl More than half went into remission, ...
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203. Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute ...
Highlights in acute lymphoblastic leukemia (ALL), presented at the American Society of Hematology (ASH) 2024 Annual Meeting and Exposition, include studies on pediatric and adult disease, as discussed ...
Research collaboration: Cure for Adults and Children with Acute Lymphoblastic Leukemia (CATCH ALL) is a research collaboration whose article contributions are accrued to its participating partner ...
Asparlas (calaspargase pegol-mknl) is a long-acting prescription injection medicine used for people with a certain type of blood cancer known as acute lymphoblastic leukemia (ALL). It is approved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results